MSD and Daiichi Sankyo have revealed some of the clinical data that prompted them to start pivotal testing of ifinatamab deruxtecan (I-DXd) in patients with previously treated, extensive-stage small ...

There's a new player on the antibody-drug conjugate (ADC) scene. UK-based Pheon Therapeutics has entered stage right with $68 million in funding that will be used to fund development of a pipeline of ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed. Chart does not reflect ...

Abstract: This paper presents a pipelined SAR ADC with a two-stage closed-loop residue amplifier (RA). The proposed RA incorporates a floating gm-ratio-based amplifier (FGA) as the first stage and a ...

This scheme has consistently delivered the best returns in its Equity - Infrastructure category across . This scheme has maintained a relatively low level of volatility within its Equity - ...